Image
Image
Image 2
Image 2
Image 3
Image 3
Image 10
Image 10
MELAS results from respiratory chain defect causing NAD+/NADH imbalance, leading to shift to anaerobic metabolism with lactate accumulation; this renders the cortex susceptible to neuronal death and vessel dysfunction.
The m.3243A>G point mutation in mtDNA (accounting for ~80% of cases) encodes tRNA for leucine and impairs mitochondrial protein production affecting multiple respiratory chain complexes.
Variable severity between patients with the same mutation reflects different percentages of mutated mtDNA in different tissues (heteroplasmy), with higher mutant burden causing more severe disease.
MELAS lesions demonstrate both cytotoxic and vasogenic edema patterns, reflecting the dual pathology of metabolic dysfunction and vascular compromise from mitochondrial angiopathy.
Serial imaging shows 'shifting spread' pattern with recurrent lesions in different locations during acute episodes, distinguishing the relapsing-remitting course from single-territory stroke.
Elevated lactate on MR spectroscopy can appear in otherwise normal-appearing brain, making it a sensitive diagnostic clue for metabolic dysfunction even when morphologic changes are subtle.
Report multifocal cortical T2/FLAIR hyperintensities with gyral swelling in parieto-occipital and parieto-temporal regions that CROSS vascular territories; specify that DWI shows restricted diffusion with variable ADC values (mixed cytotoxic and vasogenic edema); recommend MR spectroscopy to assess for elevated lactate as a diagnostic confirmation of MELAS.